200 related articles for article (PubMed ID: 32361567)
21. Interleukin-25: key regulator of inflammatory and autoimmune diseases.
Saadoun D; Terrier B; Cacoub P
Curr Pharm Des; 2011 Nov; 17(34):3781-5. PubMed ID: 22103849
[TBL] [Abstract][Full Text] [Related]
22. IL-36 receptor antagonist with special emphasis on IL-38.
Shaik Y; Sabatino G; Maccauro G; Varvara G; Murmura G; Saggini A; Rosati M; Conti F; Cianchetti E; Caraffa A; Antinolfi P; Pandolfi F; Potalivo G; Galzio R; Conti P; Theoharides TC
Int J Immunopathol Pharmacol; 2013; 26(1):27-36. PubMed ID: 23527706
[TBL] [Abstract][Full Text] [Related]
23. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI; Sfikakis PP; Bamias G
Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
[TBL] [Abstract][Full Text] [Related]
25. Cytokine Targeting by miRNAs in Autoimmune Diseases.
Salvi V; Gianello V; Tiberio L; Sozzani S; Bosisio D
Front Immunol; 2019; 10():15. PubMed ID: 30761124
[TBL] [Abstract][Full Text] [Related]
26. Boosting interleukin-10 production: therapeutic effects and mechanisms.
Zhou X; Schmidtke P; Zepp F; Meyer CU
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):465-75. PubMed ID: 16375698
[TBL] [Abstract][Full Text] [Related]
27. Induction of immunity and inflammation by interleukin-12 family members.
Alber G; Al-Robaiy S; Kleinschek M; Knauer J; Krumbholz P; Richter J; Schoeneberger S; Schuetze N; Schulz S; Toepfer K; Voigtlaender R; Lehmann J; Mueller U
Ernst Schering Res Found Workshop; 2006; (56):107-27. PubMed ID: 16329649
[TBL] [Abstract][Full Text] [Related]
28. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-15 in autoimmunity.
Allard-Chamard H; Mishra HK; Nandi M; Mayhue M; Menendez A; Ilangumaran S; Ramanathan S
Cytokine; 2020 Dec; 136():155258. PubMed ID: 32919253
[TBL] [Abstract][Full Text] [Related]
30. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
Jones SA; Jenkins BJ
Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
[TBL] [Abstract][Full Text] [Related]
31. Anti-cytokine antibodies for rheumatic diseases.
Atzeni F; Sarzi-Puttini P
Curr Opin Investig Drugs; 2009 Nov; 10(11):1204-11. PubMed ID: 19876788
[TBL] [Abstract][Full Text] [Related]
32. IL-33 and IL-33 receptors in host defense and diseases.
Oboki K; Ohno T; Kajiwara N; Saito H; Nakae S
Allergol Int; 2010 Jun; 59(2):143-60. PubMed ID: 20414050
[TBL] [Abstract][Full Text] [Related]
33. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cytokine production during phagocytosis of apoptotic cells.
Chung EY; Kim SJ; Ma XJ
Cell Res; 2006 Feb; 16(2):154-61. PubMed ID: 16474428
[TBL] [Abstract][Full Text] [Related]
35. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
36. The IL-1 family cytokines and receptors in autoimmune diseases.
Migliorini P; Italiani P; Pratesi F; Puxeddu I; Boraschi D
Autoimmun Rev; 2020 Sep; 19(9):102617. PubMed ID: 32663626
[TBL] [Abstract][Full Text] [Related]
37. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic benefits of regulating inflammation in autoimmunity.
Nikoopour E; Schwartz JA; Singh B
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-27 and Its Diverse Effects on Bacterial Infections.
Morita Y; Masters EA; Schwarz EM; Muthukrishnan G
Front Immunol; 2021; 12():678515. PubMed ID: 34079555
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 and rheumatic diseases.
Lipsky PE
Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S4. PubMed ID: 16899108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
